권호기사보기
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
---|---|---|---|---|---|---|---|---|---|
연구/단체명을 입력해주세요. |
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
Purpose: To study the concentration of vascular endothelial growth factor (VEGF) in the aqueous humor before and after intracameral injection of bevacizumab in eyes with neovascular glaucoma, and to detect the duration of an anti-VEGF effect of bevacizumab in the anterior chamber.
Methods: In this prospective interventional case series, 1.25 ㎎ of bevacizumab was injected into the anterior chamber of five eyes in five neovascular glaucoma patients. Aqueous humor samples were obtained just before intracameral injection of bevacizumab and two weeks after injection. The concentrations of VEGF in the aqueous humor were measured using ELISA. To investigate corneal endothelial damage after intrecameral bevacizumab injection, specular microscopy was performed before injection and two weeks after injection. Slit lamp photo and iris fluorescent angiography was performed to determine the regression of iris neovascularization.
Results: After injection, substantial regression of neovascularization or fluorescein leakage was seen in all treated eyes. The VEGF concentrations in the aqueous humor in eyes with NVG were 1181.8±1248.3 pg/㎖ before intracameral injection of bevacizumab. Two weeks after injection, the VEGF concentrations decreased to 33.2±12.2 pg/ ㎖ (p=0.04, Wilcoxon signed rank test). There were no significant changes in IOP or corneal endothelial cells.
Conclusions: Intracameral bevacizumab injection can remarkably reduce iris neovascularization in neovascular glaucoma patients. VEGF levels were significantly decreased two weeks after injection and corneal toxicity was not observed during short term follow-up.번호 | 참고문헌 | 국회도서관 소장유무 |
---|---|---|
1 | Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma ![]() |
미소장 |
2 | Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma ![]() |
미소장 |
3 | Extracellular Modulating Factors and the Control of Intraocular Neovascularization ![]() |
미소장 |
4 | Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. ![]() |
미소장 |
5 | Growth factors in the aqueous humor and their clinical significance. ![]() |
미소장 |
6 | Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. ![]() |
미소장 |
7 | Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma ![]() |
미소장 |
8 | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. ![]() |
미소장 |
9 | Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. ![]() |
미소장 |
10 | Intravitreal Bevacizumab (Avastin) Injection for Neovascular Glaucoma ![]() |
미소장 |
11 | Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. ![]() |
미소장 |
12 | Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration ![]() |
미소장 |
13 | Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman Primate ![]() |
미소장 |
14 | Intravitreal Bevacizumab (Avastin ®) in the Treatment of Neovascular Glaucoma ![]() |
미소장 |
15 | Intraviteal Bevacizumab (Avastin(R)) Injection for the Treatment of Early-Stage Neovascular Glaucoma | 소장 |
16 | Vascular endothelial growth factor. ![]() |
미소장 |
17 | Effect of Bevacizumab on Human Corneal Endothelial Cells: A Six-month Follow-up Study ![]() |
미소장 |
18 | Safety Profile of Bevacizumab on Cultured Human Corneal Cells ![]() |
미소장 |
*표시는 필수 입력사항입니다.
*전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
---|
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.